News & Highlights
Clinical Trials
NIH Spent $8.1B for Phased Clinical Trials of Drugs Approved 2010-19, ~10% of Reported Industry Spending
July 21, 2023 | Bentley University study further describes public and private sector investments in pharmaceutical innovation.
Read story
NIH Toughens Enforcement of Delayed Clinical Trials Reporting
June 5, 2023 | Agency says it has brought more than 200 tardy investigators into compliance since July 2022.
Read story
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
January 17, 2023 | Diversifying clinical trials could build trust in new treatments among Black people and their physicians.
Read story
More Data Needed
July 7, 2022 | Study shows females underrepresented in key disease clinical trials.
Read story
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 | New research from the NIH shows promising results for adult COVID-19 patients.
Read story
Studies Reveal Key Clues about COVID-19 Immunity
May 19, 2022 | A trio of newly published studies provide clues about COVID-19 immunity.
Read story
The Essentials of Single IRB Review
May 6, 2022 | Facilitating more than 300 COVID-19-related multisite studies, SMART IRB has become an integral part of the fabric of collaborative research across the U.S.
Read story
Five Questions with Hanny Al-Samkari
March 7, 2022 | A classical hematologist discusses how our training programs have impacted his career.
Read story